Oramed Pharmaceuticals Inc. ORMP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

Oramed Pharmaceuticals Inc. (ORMP) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Lee James G avec 10,069,013 actions. Parmi les autres détenteurs notables Bronfeld Zeev et KIDRON NADAV.

Au cours des 12 derniers mois, les initiés ont effectué 25 transactions sur ORMP l'action — 17 achats (d'une valeur de $1.44K) et 0 ventes (d'une valeur de RSU Award). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.

ORMP Participations des Initiés

Principal Actionnaire

Lee James G

10,069,013 actions

Achats (12 mois)

$1.44K valeur

Ventes (12 mois)

$0.00 valeur

Activité de transactions (12 mois)

Acheter 68%

Vendre 0%

Principaux actionnaires initiés

#	Nom	Rôle	Actions détenues	Dernière déclaration	Taille relative
1	Lee James G	CEO	10,069,013	2004-06-03	100%
2	Bronfeld Zeev	10 Percent Owner	5,808,517	2011-10-05	58%
3	Kidron Nadav	President and CEO	3,422,243	2026-03-31	34%
4	Hexter Joshua	COO & Cbo	1,160,384	2026-03-18	12%
5	Kidron Miriam	Chief Scientific Officer	1,133,138	2026-03-31	11%
6	Orlev Chaime	CFO, Treasurer and Secretary	828,000	2008-10-16	8%
7	Gabay Avraham	Chief Financial Officer	745,145	2026-03-18	7%
8	Silberman David	Chief Financial Officer	366,500	2024-01-08	4%
9	Li Xiaopeng	Director	206,350	2017-08-03	2%
10	Mayer Arie	Director	163,109	2026-01-05	2%
11	Derovan Netanel	Chief Legal Officer	149,500	2023-05-31	1%
12	Rozov Yadin	Director	146,500	2024-01-08	1%
13	Sank Leonard	Director	128,021	2025-06-09	1%
14	Rabinowitz Michael	Chief Commercial Officer	126,143	2023-01-04	1%
15	Shapiro Benjamin	Director	119,720	2026-01-05	1%
16	Aghion Daniel	Director	107,191	2026-01-02	1%
17	Reznick Yehuda	Director	98,930	2026-01-05	1%
18	Rakin Kevin	Director	46,661	2022-03-22	0%
19	Law Ronald Edward	Chief Strategy Officer	37,152	2017-03-21	0%
20	Eisenberg Hilla	CFO, Treasurer and Secretary	37,000	2019-02-28	0%

Transactions récentes (12 derniers mois)

Date	Nom	Rôle	Type	Actions	Prix	Valeur
2026-03-30	Kidron Miriam	Chief Scientific Officer	Retenue Fiscale RSU	435,084	$3.31	$1.44M
2026-03-30	Kidron Nadav	President and CEO	Retenue Fiscale RSU	44,818	$3.31	$148.35K
2026-03-17	Gabay Avraham	Chief Financial Officer	Attribution de RSU	95,889	-	-
2026-03-17	Hexter Joshua	COO & Cbo	Attribution de RSU	95,889	-	-
2026-03-17	Kidron Miriam	Chief Scientific Officer	Attribution de RSU	119,558	-	-
2026-03-17	Kidron Nadav	President and CEO	Attribution de RSU	167,005	-	-
2026-03-12	Kidron Nadav	President and CEO	Don (Donné)	100,000	-	-
2026-01-22	Gabay Avraham	Chief Financial Officer	Exercice d'Options (Vente)	19,000	-	-
2026-01-22	Hexter Joshua	COO & Cbo	Exercice d'Options (Vente)	19,000	-	-
2026-01-22	Kidron Miriam	Chief Scientific Officer	Exercice d'Options (Vente)	19,000	-	-
2026-01-22	Kidron Nadav	President and CEO	Exercice d'Options (Vente)	109,000	-	-
2026-01-14	Kidron Miriam	Chief Scientific Officer	Don (Donné)	86,166	-	-
2025-12-31	Reznick Yehuda	Director	Attribution de RSU	30,000	$0.01	$360.00
2025-12-31	Shapiro Benjamin	Director	Attribution de RSU	30,000	$0.01	$360.00
2025-12-31	Mayer Arie	Director	Attribution de RSU	30,000	$0.01	$360.00
2025-12-31	Hexter Joshua	COO & Cbo	Attribution de RSU	19,000	-	-
2025-12-31	Kidron Miriam	Chief Scientific Officer	Attribution de RSU	19,000	-	-
2025-12-31	Kidron Nadav	President and CEO	Attribution de RSU	109,000	-	-
2025-12-31	Aghion Daniel	Director	Attribution de RSU	30,000	$0.01	$360.00
2025-12-31	Gabay Avraham	Chief Financial Officer	Attribution de RSU	19,000	-	-
2025-06-05	Reznick Yehuda	Director	Attribution de RSU	30,000	-	-
2025-06-05	Aghion Daniel	Director	Attribution de RSU	30,000	-	-
2025-06-05	Shapiro Benjamin	Director	Attribution de RSU	30,000	-	-
2025-06-05	Mayer Arie	Director	Attribution de RSU	30,000	-	-
2025-06-05	Sank Leonard	Director	Attribution de RSU	30,000	-	-